Peer-reviewedLicence not statedJournal of Nuclear Medicine3 Nov 2026

Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor–Targeted [89Zr]Zr-Panitumumab PET/CT

Joseph Hoang¹
Kyrionna Golliday²
Ashtyn McAdoo²
Adam Rosenberg^1,3
Kamal Jouad³
Eben Rosenthal²
Michael C. Topf²

¹Department of Radiology, Vanderbilt Health, Nashville, Tennessee
²Department of Otolaryngology, Vanderbilt Health, Nashville, Tennessee; and
³Vanderbilt University Institute of Imaging Science, Nashville, Tennessee

Factors Influencing the Treatment Response of Tetracyclines for Papulopustular Rash Induced by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Retrospective Study.
Tae Min Kim, Namkyu Kim, Jimin Woo +3
Dermatology practical & conceptual31 Jul 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
Amivantamab and lazertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer with brain and leptomeningeal metastases: an editorial on efficacy, challenges in assessment, and future directions.
Vinay R Nittur, Yoojin Jo, Misako Nagasaka
Translational lung cancer research26 Oct 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review
Naoto Minematsu, Yoko Imai, Toshiyuki Hirano +1
Internal Medicine1 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
Complete Response to First-Line Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Extra-axial Central Nervous System Metastases.
Maria João Oura, Rita Pinho, Fernando Osório +2
Cureus24 Sep 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
The role of the epidermal growth factor receptor (EGFR/ErbB1) in diabetic retinopathy and its therapeutic implications.
Marwan Malluhi, Dina Tluli, Saghir Akhtar
Journal of translational medicine1 Jul 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ

Cite

BibTeX

@article{hoang2026evaluating,
  title = {{Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor–Targeted [89Zr]Zr-Panitumumab PET/CT}},
  author = {Joseph Hoang and Kyrionna Golliday and Ashtyn McAdoo and Adam Rosenberg and Kamal Jouad and Eben Rosenthal and Michael C. Topf},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  month = nov,
  doi = {10.2967/jnumed.125.271333},
  url = {https://doi.org/10.2967/jnumed.125.271333},
}

RIS

TY  - JOUR
TI  - Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor–Targeted [89Zr]Zr-Panitumumab PET/CT
AU  - Joseph Hoang
AU  - Kyrionna Golliday
AU  - Ashtyn McAdoo
AU  - Adam Rosenberg
AU  - Kamal Jouad
AU  - Eben Rosenthal
AU  - Michael C. Topf
PY  - 2026
DA  - 2026/11/03
JO  - Journal of Nuclear Medicine
DO  - 10.2967/jnumed.125.271333
UR  - https://doi.org/10.2967/jnumed.125.271333
SN  - 0161-5505
SN  - 1535-5667
ER  -

Related

Cite